Virtu Financial LLC Gilead Sciences, Inc. Transaction History

Virtu Financial LLC

$1.82 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $3.06 Million - $3.53 Million	-48,413 Reduced 76.54%	14,838 $1.02 Million
Q1 2024 May 20, 2024	BUY	$71.58 - $87.29 $4.53 Million - $5.52 Million	63,251 New	63,251 $4.63 Million
Q4 2022 Feb 15, 2023	BUY	$62.32 - $89.47 $240,555 - $345,354	3,860 Added 87.45%	8,274 $710,000
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $262,809 - $300,196	4,414 New	4,414 $272,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $1.8 Million - $2.03 Million	-31,185 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$57.92 - $72.58 $1.81 Million - $2.26 Million	31,185 New	31,185 $1.85 Million
Q4 2020 Feb 24, 2021	SELL	$56.65 - $64.55 $608,477 - $693,331	-10,741 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$62.1 - $78.08 $667,016 - $838,657	10,741 New	10,741 $679,000
Q2 2020 Aug 07, 2020	SELL	$72.34 - $84.0 $2.55 Million - $2.96 Million	-35,292 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $966,694 - $1.06 Million	-15,688 Reduced 30.77%	35,292 $2.29 Million
Q3 2019 Nov 20, 2019	SELL	$62.51 - $69.0 $993,596 - $1.1 Million	-15,895 Reduced 23.77%	50,980 $3.23 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $2.24 Million - $2.51 Million	36,243 Added 118.32%	66,875 $4.52 Million
Q1 2019 Apr 12, 2019	SELL	$62.53 - $70.05 $280,884 - $314,664	-4,492 Reduced 12.79%	30,632 $1.99 Million
Q4 2018 Jan 16, 2019	BUY	$60.54 - $79.0 $2.13 Million - $2.77 Million	35,124 New	35,124 $2.2 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $208,494 - $230,841	-2,925 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$64.88 - $75.68 $317,263 - $370,075	-4,890 Reduced 62.57%	2,925 $207,000
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $1.99 Million - $2.43 Million	-27,388 Reduced 77.8%	7,815 $589,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $96,692 - $113,503	1,359 Added 4.02%	35,203 $2.52 Million
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $2.44 Million - $2.89 Million	33,844	33,844 $1.19 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Account